Oncology
epub |eng | | Author:Herman D. Suit & Jay S. Loeffler

8.3.3 Leo Gerweck Leo became a member of the laboratory research program in 1974 shortly after receiving his Ph.D. from Colorado State University with W. Dewey as his thesis advisor. ...
( Category: Radiology August 14,2020 )
epub |eng | 2014-08-15 | Author:Abrams, Donald I.; Weil, Andrew;

REDUCING OR RELIEVING CANCER-RELATED PAIN Pain is both a physical sensation and an emotional experience. It is one of the most common, burdensome, and feared symptoms experienced by patients with ...
( Category: Oncology August 6,2020 )
epub |eng | | Author:Raouf E. Nakhleh

Subspecialty Diagnostic Threshold and Error Subspecialized sign-out and specialist review may improve error rates and help to optimize patient care, particularly in challenging diagnoses. However, the threshold of certain diagnosis ...
( Category: Pathology August 6,2020 )
epub |eng | 2016-08-14 | Author:Cormack, Robert A.,Holloway, Caroline,Devlin, Phillip M.,Stewart, Alexandra J.

DOSE RATE CONSIDERATIONS: LDR, HDR, AND PDR The prescribed dose and dose rate are important considerations, which take into account clinical, anatomic, and radiobiologic considerations. Specific dose recommendations by head ...
( Category: Radiology August 5,2020 )
epub, pdf |eng | 2011-04-20 | Author:Devra Davis

A Breast Cancer Fund poster, banned in San Francisco in January 2000.The superimposed mastectomy scar is that of the author’s friend Andrea Martin. 11 Doctoring Evidence You can observe a ...
( Category: Oncology July 25,2020 )
epub |eng | | Author:Saad Z. Usmani & Ajay K. Nooka

5.9.1.2 Carfilzomib, Cyclophosphamide, and Dexamethasone (CCyD) Carfilzomib has also been combined with cyclophosphamide and dexamethasone as a treatment regimen in a phase II study newly diagnosed patients who were not ...
( Category: Hematology July 22,2020 )
epub |eng | | Author:Meletios A. Dimopoulos, Thierry Facon & Evangelos Terpos

Patients with Asymptomatic Myeloma (AMM) Intravenous PAM (60–90 mg monthly for 12 months) in patients with AMM reduced bone involvement at progression but did not decrease the risk and increase ...
( Category: Hematology July 22,2020 )
epub |eng | | Author:Jaspreet S. Sandhu

15. Gomha MA, Boone TB. Artificial urinary sphincter for post-prostatectomy incontinence in men who had prior radiotherapy: a risk and outcome analysis. J Urol. 2002;167:591–6.CrossRefPubMed 16. Ravier E, Fassi-Fehri H, ...
( Category: Urology July 21,2020 )
epub |eng | 2018-07-21 | Author:David J. Hess

( Category: Microbiology July 21,2020 )
epub |eng | | Author:Paul Imbach, Thomas Kühne & Robert J. Arceci

Radiotherapy:In radical resection of tumor, 40–50 Gy, but higher doses with hyperfractionation High rate of morbidity Chemotherapy:Only in exceptional situations, depending on the tumor type (diffuse infiltrating character) Effective drugs ...
( Category: Hematology July 21,2020 )
azw3 |eng | 2020-07-02 | Author:DiPiro, Joseph T. & Yee, Gary C. & Posey, L. Michael [DiPiro, Joseph T.]

( Category: Oncology July 12,2020 )
epub |eng | | Author:Akila N. N. Viswanathan, Christian Kirisits, Beth E. E. Erickson & Richard Pötter

12.2.5 Applicator Reconstruction Using MR Images Localizing the source path from MR images is challenging because conventional markers used for X-ray and CT cannot be used in magnetic resonance imaging ...
( Category: Obstetrics & Gynecology July 10,2020 )
epub |eng | | Author:Christopher L. Skelly & Ross Milner

P (patients) I (intervention) C (comparator group) O (outcomes measured) Patients with chronic mesenteric ischemia Single-vessel repair Multi-vessel repair Freedom from symptoms; long-term freedom from restenosis; long-term freedom from recurrence ...
( Category: Oncology July 10,2020 )
epub |eng | 2020-03-27 | Author:Mikkael A. Sekeres [Sekeres, Mikkael]

Figure 5.2 The general course of events for a patient with acute myeloid leukemia receiving chemotherapy in the hospital. The Ara-C finishes infusing on Day 8, the bone marrow biopsy ...
( Category: Oncology July 9,2020 )
epub, pdf |eng | | Author:John Alexander Pinkston

2.Was allocation adequately concealed? 3.Was knowledge of allocated intervention adequately prevented during the trial from patients, personnel, and outcome assessors (i.e., adequate “blinding”)? 4.Were incomplete outcome data adequately addressed? 5.Are ...
( Category: Oncology July 8,2020 )